Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents

被引：0
|
作者：
Tsao, Lulu [1 ]
Otani, Iris M. [2 ]
Bove, Riley [3 ]
机构：
[1] UCSF, Dept Med, San Francisco, CA USA
[2] UCSF, Dept Internal Med, Div Allergy & Immunol, San Francisco, CA USA
[3] UCSF, Dept Neurol, San Francisco, CA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
49
引用
收藏
页码：AB17 / AB17
页数：1
相关论文
共 50 条
  • [41] Quality of life for veterans with multiple sclerosis on disease-modifying agents: Relationship to disability
    Guarnaccia, Joseph B.
    Aslan, Mihaela
    O'Connor, Theresa Z.
    Hope, MaryAnn
    Kazis, Lewis
    Kashner, C. Michael
    Booss, John
    [J]. JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2006, 43 (01): : 35 - 44
  • [42] COMPARATIVE ADHERENCE TRAJECTORIES ACROSS ORAL DISEASE-MODIFYING AGENTS IN MULTIPLE SCLEROSIS
    Earla, J. R.
    Hutton, G. J.
    Aparasu, R. R.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S303 - S303
  • [43] Emerging multiple sclerosis disease-modifying therapies
    Giacomini, Paul S.
    Darlington, Peter J.
    Bar-Or, Amit
    [J]. CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 226 - 232
  • [44] Cost of disease-modifying therapies for multiple sclerosis
    Brown, Murray G.
    [J]. NEUROLOGY, 2015, 84 (21) : E181 - E185
  • [45] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [46] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
  • [47] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    [J]. CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [48] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    [J]. Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
  • [49] Use of Disease-Modifying Drugs in Multiple Sclerosis
    Wurzius, F. Q.
    Silva, C. B.
    de Vecino, M. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 102 - 103
  • [50] Oral Disease-Modifying Therapies for Multiple Sclerosis
    Kim, Woojun
    Zandona, Manuella Edler
    Kim, Su-Hyun
    Kim, Ho Jin
    [J]. JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 9 - 19
12345